Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality.
Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR, Rose EA, Levin HR, Oz MC. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 1995 May; 59(5):1063-7; discussion 1068.